AWA
SMTI icon

Arete Wealth Advisors’s Sanara MedTech SMTI Stock Holding History

Arete Wealth Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,400
Closed -$247K – 445
2020
Q4 		$247K Buy
+5,400
New +$213K 0.04% 345

Other funds holding SMTI

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Arete Wealth Advisors's SMTI Position: Q1 2021 in Review

Arete Wealth Advisors sold out of Sanara MedTech (SMTI) in Q1 2021, closing a stake of 5,400 shares — an estimated $247K sold.

Arete Wealth Advisors first reported a position in SMTI in Q4 2020 and held it in 1 quarter. The position peaked at $247K in Q4 2020. 20 funds tracked by Wall St. Rank hold SMTI as of Q1 2021.

  • Arete Wealth Advisors reported no remaining Sanara MedTech position as of Q1 2021 after selling out during the quarter.
  • Arete Wealth Advisors sold 5,400 Sanara MedTech shares in Q1 2021, an estimated $247K.
  • Arete Wealth Advisors first reported a position in Sanara MedTech in Q4 2020 and held it in 1 quarter.
  • Arete Wealth Advisors's Sanara MedTech position peaked at $247K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2021.

Based on Arete Wealth Advisors's 13F filing for Q1 2021, filed 10 May 2021.